BCL2L11 and glioblastoma: Furthermore, glucocorticoids, which are often used in the management of GBM, repress the expression of miR-17-92 in lymphocytes, thereby up-regulating proapoptotic Bim as a mechanism inducing apoptotic death of lymphoid cells[32].